UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037633
Receipt number R000042911
Scientific Title Trial of the effect of food ingredients and exercise on muscle function (SWE-2019-05-HBLOCO)
Date of disclosure of the study information 2021/02/28
Last modified on 2021/12/07 17:47:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Trial of the effect of food ingredients and exercise on muscle function (SWE-2019-05-HBLOCO)

Acronym

Trial of the effect of food ingredients and exercise on muscle function

Scientific Title

Trial of the effect of food ingredients and exercise on muscle function (SWE-2019-05-HBLOCO)

Scientific Title:Acronym

Trial of the effect of food ingredients and exercise on muscle function

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of nutrition and exercise on muscle function

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The amount of changes in femoral muscle cross-sectional area during the 24th week intervention period

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food Behavior,custom

Interventions/Control_1

Supplementation of low-dose food ingredient and exercise

Interventions/Control_2

Supplementation of high-dose food ingredient and exercise

Interventions/Control_3

Supplementation of placebo and exercise

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Women and men aged 50 to 74 years at the time of acquisition of agreement in participating in this study
2) Person who does not engage regular exercise.
3) Person who can come to the medical organization for the measurement at the date of visiting
4) Person who can understand the purpose and content of this study and agree in writing to participate in this study

Key exclusion criteria

1) Presence of disease in locomotor organs affecting the efficacy assessment of this study.
2) Presence of health problems to perform exercise.
3) Use of supplement affecting the data of this study.
4) With previous and present serious disease such as cardiac affection, liver disorder, kidney disorder, cardiovascular disorder, lung disorder, diabetes mellitus.
5) Investigator's judgment for other reason.

Target sample size

54


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Izumo

Organization

Suntory Wellness Limited

Division name

Institute For Health Care Science

Zip code

619-0284

Address

8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto

TEL

050-3182-0630

Email

Takayuki_Izumo@suntory.co.jp


Public contact

Name of contact person

1st name Yuta
Middle name
Last name Otsuka

Organization

Suntory Wellness Limited

Division name

Institute For Health Care Science

Zip code

619-0284

Address

8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto

TEL

050-3182-0671

Homepage URL


Email

Yuta_Otsuka@suntory.co.jp


Sponsor or person

Institute

Suntory Wellness Limited

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuda Clinic

Address

1-6-1 Miyahara, Yodogawa-ku, Osaka

Tel

06-6398-0203

Email

fukudaclinicIRB@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 08 Month 06 Day

Date of IRB

2019 Year 06 Month 15 Day

Anticipated trial start date

2019 Year 08 Month 10 Day

Last follow-up date

2020 Year 03 Month 19 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 08 Day

Last modified on

2021 Year 12 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042911


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name